Indrayani Biotech will hold a Rights Issue Committee meeting on April 9, 2026, to finalize details of a partly paid-up rights issue.
The committee will determine key parameters including issue size, price, entitlement ratio, and record date for the rights issue.
It will also appoint a monitoring agency and banker to manage the issue process and fund flows.